James Bilsborrow, a Weitz & Luxenberg partner and practice group co-chair, is speaking at a virtual event titled “PFAS Litigation and Regulatory Developments Conference.” It…
Read MoreFirm News: Drugs & Devices: Page 5
Category: Drugs & Devices
Philips Recalls PAP, CPAP and Ventilator Devices in U.S. Due to Health Risks
UPDATE 4/19/2022: Read the most current information about this litigation. Philips announced a voluntary recall of some of its sleep and respiratory care devices in…
Category: Drugs & Devices, Our Firm
McDonough Explains to AAJ How to Prevent Snap Removals
Trial, the magazine published by the American Association for Justice (AAJ), has an article coauthored by Weitz & Luxenberg associate attorney Brendan A. McDonough…
W&L Representing Talc Users Diagnosed with Certain Cancers
Weitz & Luxenberg P.C. has been and continues to represent people who have been using talc regularly and consistently for several years and were…
Category: Drugs & Devices
W&L Attorney Gold Appointed to Elmiron MDL Leadership
Attorney Danielle Gold has been appointed to serve on the Plaintiffs’ Executive Committee in the Elmiron multidistrict litigation (MDL). The litigation alleges that taking…
Category: Drugs & Devices
W&L Taking Penumbra Recalled JET 7 Catheters with Xtra Flex Technology Cases
According to the U.S. Food and Drug Administration (FDA), the medical device manufacturer Penumbra issued an urgent voluntary recall of the Penumbra JET 7…